Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-29

Clinical Trial Update: Postprandial Effects of Walnut Components Versus Whole Walnuts on Cardiovascular Disease (CVD) Risk Reduction [NA]

View source ↗

Summary

Completed clinical trial evaluating postprandial effects of walnut components versus whole walnuts on cardiovascular disease risk markers; results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Penn State University | Conditions: Cardiovascular Disease | NA | Status: COMPLETED | Results posted: 2018-10-29